Delivery Order SPE2DB20D3101-SPE2DB25FRRN8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,487.60 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml cartridges on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract represents a non-set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Imitrex is a migraine treatment medication, and this delivery order fulfills specific pharmaceutical supply needs for federal healthcare...
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Imitrex 6 mg/0.5 ml cartridges with a ceiling value of $9,023.44 under a firm fixed price arrangement. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single transaction within...
- The Defense Logistics Agency (DLA) awarded a $5,155.59 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges (0.5 mL units). This firm fixed-price contract represents a non-competitive delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,107.71 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on August 18, 2025, with a completion date of August 19, 2025. This firm fixed price delivery order represents a continuation of pharmaceutical supply support to federal medical procurement needs, specifically supporting military and veteran healthcare systems. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges valued at $20,917.11. This firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is executed as a child...
- On July 29, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a $2,905.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 mL pen injectors. This is a non-set-aside contract awarded through open competition, with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 mL cartridges. The $3,155.06 firm-fixed-price contract has a completion date of January 31, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.54 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitive award carries firm fixed pricing and involves no set-aside designation. The pharmaceutical product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a ceiling value of $1,819.68 and a period of performance through April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides...
- AmerisourceBergen Drug Corp was awarded a $2,451.26 delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injector (0.5 mL). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive award outside of any set-aside program. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRN8Delivery Order
The Defense Logistics Agency awarded a $14,682.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 mL cartridges (0.5 mL), with an ultimate completion date of August 1, 2025. This non-set-aside contract was competitively awarded on July 31, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs worldwide. Imitrex, a migraine treatment medication, supports the Defense Health Agency and other government healthcare systems' pharmaceutical needs, demonstrating AmerisourceBergen's role as a critical vendor for federal medical procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 7/31/25 |